These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24929808)

  • 1. Prognostic significance of immunohistochemical expression of VEGFR2 and iNOS in spinal chordoma.
    Akhavan-Sigari R; Gaab MR; Rohde V; Abili M; Ostertag H
    Eur Spine J; 2014 Nov; 23(11):2416-22. PubMed ID: 24929808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth factor receptor 2 (VEGFR-2), inducible nitric oxide synthase (iNOS), and Ki-M1P in skull base chordoma: a series of 145 tumors.
    Akhavan-Sigari R; Gaab MR; Rohde V; Brandis A; Tezval H; Abili M; von Eckardstein K; Ostertag H
    Neurosurg Rev; 2014 Jan; 37(1):79-88. PubMed ID: 23999886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma.
    Morimoto Y; Tamura R; Ohara K; Kosugi K; Oishi Y; Kuranari Y; Yoshida K; Toda M
    J Neurooncol; 2019 Aug; 144(1):65-77. PubMed ID: 31240525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.
    Stacchiotti S; Casali PG; Lo Vullo S; Mariani L; Palassini E; Mercuri M; Alberghini M; Pilotti S; Zanella L; Gronchi A; Picci P
    Ann Surg Oncol; 2010 Jan; 17(1):211-9. PubMed ID: 19847568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Treatment of Sacral Chordoma: En Bloc Resection with Negative Margins is a Determinant of the Long-Term Outcome.
    Colangeli S; Muratori F; Bettini L; Frenos F; Totti F; D'Arienzo A; Campo FR; Scoccianti G; Beltrami G; Campanacci DA; Capanna R
    Surg Technol Int; 2018 Nov; 33():343-348. PubMed ID: 30204925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival.
    Varga PP; Szövérfi Z; Fisher CG; Boriani S; Gokaslan ZL; Dekutoski MB; Chou D; Quraishi NA; Reynolds JJ; Luzzati A; Williams R; Fehlings MG; Germscheid NM; Lazary A; Rhines LD
    Eur Spine J; 2015 May; 24(5):1092-101. PubMed ID: 25533857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis.
    Froehlich EV; Scheipl S; Lazàry A; Varga PP; Schmid C; Stammberger H; Beham A; Bodo K; Schroettner H; Quehenberger F; Windhager R; Liegl B; Leithner A
    Spine (Phila Pa 1976); 2012 Jun; 37(13):E757-67. PubMed ID: 22228328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.
    Gokaslan ZL; Zadnik PL; Sciubba DM; Germscheid N; Goodwin CR; Wolinsky JP; Bettegowda C; Groves ML; Luzzati A; Rhines LD; Fisher CG; Varga PP; Dekutoski MB; Clarke MJ; Fehlings MG; Quraishi NA; Chou D; Reynolds JJ; Williams RP; Kawahara N; Boriani S
    J Neurosurg Spine; 2016 Apr; 24(4):644-51. PubMed ID: 26682601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot study.
    Hobusch GM; Bodner F; Walzer S; Marculescu R; Funovics PT; Sulzbacher I; Windhager R; Panotopoulos J
    World J Surg Oncol; 2016 Apr; 14():111. PubMed ID: 27091202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors.
    Rotondo RL; Folkert W; Liebsch NJ; Chen YL; Pedlow FX; Schwab JH; Rosenberg AE; Nielsen GP; Szymonifka J; Ferreira AE; Hornicek FJ; DeLaney TF
    J Neurosurg Spine; 2015 Dec; 23(6):788-97. PubMed ID: 26340383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma.
    Chen KW; Yang HL; Lu J; Wang GL; Ji YM; Wu GZ; Zhu LF; Liu JY; Chen XQ; Gu YP
    J Neurooncol; 2011 Feb; 101(3):357-63. PubMed ID: 20549300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in the operative management of dedifferentiated sacral chordomas.
    Kayani B; Sewell MD; Hanna SA; Saifuddin A; Aston W; Pollock R; Skinner J; Molloy S; Briggs TW
    Neurosurgery; 2014 Sep; 75(3):269-75; discussion 275. PubMed ID: 24867206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical outcome of recurrent sacral chordoma with further surgical treatment.
    Yang Y; Li Y; Liu W; Xu H; Niu X
    Medicine (Baltimore); 2018 Dec; 97(52):e13730. PubMed ID: 30593146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients.
    Hsieh PC; Xu R; Sciubba DM; McGirt MJ; Nelson C; Witham TF; Wolinksy JP; Gokaslan ZL
    Spine (Phila Pa 1976); 2009 Sep; 34(20):2233-9. PubMed ID: 19752710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors in Surgical Patients with Chordomas of the Cervical Spine: A Study of 52 Cases from a Single Institution.
    Zhou H; Jiang L; Wei F; Joeris A; Hurtado-Chong A; Kalampoki V; Rometsch E; Yu M; Wu F; Dang L; Liu X; Liu Z
    Ann Surg Oncol; 2017 Aug; 24(8):2355-2362. PubMed ID: 28593502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of local recurrence and cure in low grade malignant tumors of the spine.
    Boriani S; Saravanja D; Yamada Y; Varga PP; Biagini R; Fisher CG
    Spine (Phila Pa 1976); 2009 Oct; 34(22 Suppl):S48-57. PubMed ID: 19829277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients.
    Bergh P; Kindblom LG; Gunterberg B; Remotti F; Ryd W; Meis-Kindblom JM
    Cancer; 2000 May; 88(9):2122-34. PubMed ID: 10813725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience.
    Molina CA; Ames CP; Chou D; Rhines LD; Hsieh PC; Zadnik PL; Wolinsky JP; Gokaslan ZL; Sciubba DM
    J Neurosurg Spine; 2014 Sep; 21(3):348-56. PubMed ID: 24926926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients.
    Zou MX; Huang W; Wang XB; Li J; Lv GH; Wang B; Deng YW
    Eur Spine J; 2015 Aug; 24(8):1738-46. PubMed ID: 25850393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.